Cargando…
RBL2 Regulates Cardiac Sensitivity to Anthracycline Chemotherapy
BACKGROUND: Anthracycline chemotherapies cause heart failure in a subset of cancer patients. We previously reported that the anthracycline doxorubicin (DOX) induces cardiotoxicity through the activation of cyclin-dependent kinase 2 (CDK2). OBJECTIVES: The aim of this study was to determine whether r...
Autores principales: | Xia, Peng, Chen, Jingrui, Sapkota, Yadav, Scott, Erika N., Liu, Yuening, Hudson, Melissa M., Rassekh, Shahrad R., Carleton, Bruce C., Ross, Colin J.D., Chow, Eric J., Cheng, Zhaokang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308060/ https://www.ncbi.nlm.nih.gov/pubmed/37397090 http://dx.doi.org/10.1016/j.jaccao.2022.10.017 |
Ejemplares similares
-
Loss of Rbl2 (Retinoblastoma‐Like 2) Exacerbates Myocardial Ischemia/Reperfusion Injury
por: Chen, Jingrui, et al.
Publicado: (2022) -
A Coding Variant in RARG Confers Susceptibility to Anthracycline-Induced Cardiotoxicity in Childhood Cancer
por: Aminkeng, Folefac, et al.
Publicado: (2015) -
Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
por: Wright, Galen E.B., et al.
Publicado: (2018) -
Cell Cycle Proteins as Key Regulators of Postmitotic Cell Death
por: Xia, Peng, et al.
Publicado: (2019) -
Harnessing Genomics to Predict and Prevent Anthracycline-Associated Cardiotoxicity
por: Sapkota, Yadav
Publicado: (2020)